Association of clinic vascular access monitoring practices with clinical outcomes in hemodialysis patients

Nephron - Clinical Practice

Volumn 104, Issue 4, 2006, Pages

  Plantinga, Laura C ^a   Jaar, Bernard G ^a,b   Astor, Brad ^a,b   Fink, Nancy E ^a,b   Eustace, Joseph A ^a   Klag, Michael J ^a,b   Powe, Neil R ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Hospitalization; Mortality; Septicemia; Vascular access patency; Vascular access surveillance

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; COHORT ANALYSIS; FEMALE; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTICEMIA; SURVIVAL; VASCULAR ACCESS;

COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OUTCOME ASSESSMENT (HEALTH CARE); RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; STATISTICS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 33845345906     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094961     Document Type: Article

References (31)

1. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-535.
2. Anel RL, Yevzlin AS, Ivanovich P: Vascular access and patient outcomes in hemodialysis: questions answered in recent literature. Artif Organs 2003;27:237-241.
3. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-535.
4. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA: Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091-1096.
5. McCarley P, Wingard RL, Shyr Y, Pettus W, Hakim RM, Ikizler TA: Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int 2001;60:1164-1172.
6. National Kidney Foundation: Kidney Disease Outcomes Quality Initiative (K/DOQI). http://www.kidney.org/professionals/ KDOQI/. National Kidney Foundation, 2005.
7. Safa AA, Valji K, Roberts AC, Ziegler TW, Hye RJ, Oglevie SB: Detection and treatment of dysfunctional hemodialysis access grafts: effect of a surveillance program on graft patency and the incidence of thrombosis. Radiology 1996;199:653-657.
8. Vanholder R: Vascular access: care and monitoring of function. Nephrol Dial Transplant 2001;16:1542-1545.
9. Work J: Does vascular access monitoring work? Adv Ren Replace Ther 2002;9:85-90.
10. Powe NR, Klag MJ, Sadler JH, Anderson GF, Bass EB, Briggs WA, Fink NE, Levey AS, Levin NW, Meyer KB, Rubin HR, Wu AW: Choices for healthy outcomes in caring for end stage renal disease. Semin Dial 1996;9:9-11.
11. Plantinga LC, Fink NE, Sadler JH, Levey AS, Levin NW, Rubin HR, Coresh J, Klag MJ, Powe NR: Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol 2004;15:210-218.
12. Plantinga LC, Fink NE, Jaar BG, Sadler JH, Coresh J, Klag MJ, Levey AS, Powe NR: Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients. J Am Soc Nephrol 2004;15:3144-3153.
13. Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, Fink NE, Coresh J: Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis 2001;38:494-501.
14. Daugirdas JT: Second-generation logarithmic estimates of single-pool variable volume of Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1204-1213.
15. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999;55:1081-1090.
16. Greenfield S, Apolone G, McNeil BJ, Cleary PD: The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: comorbidity and outcomes after hip replacement. Med Care 1993;31:141-154.
17. Athienites NV, Miskulin DC, Fernandez G, Bunnapradist S, Simon G, Landa M, Schmid CH, Greenfield S, Levey AS, Meyer KB: Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial 2000;13:320-326.
18. Miskulin DC, Meyer KB, Athienites NV, Martin AA, Terrin N, Marsh JV, Fink NE, Coresh J, Powe NR, Klag MJ, Levey AS: Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2000;39:324-336.
19. Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW, Meyer KB, Levey AS: Comorbidity assessment using the Index of Coexistent Diseases in a multi-center clinical trial. Kidney Int 2001;60:1498-1510.
20. Localio AR, Berlin JA, Ten Have TR, Kimmel SE: Adjustments for center in multicenter studies: an overview. Ann Intern Med 2001;135:112-123.
21. Wei LJ, Lin DY, Weissfeld L: Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-1073.
22. Lin DY, Wei LJ: The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989;84:1074-1078.
23. Himmelfarb J, Pereira BJ, Wesson DE, Smedberg PC, Henrich WL: Payment for quality in end-stage renal disease. J Am Soc Nephrol 2004;15:3263-3269.
24. Tessitore N, Lipari G, Poli A, Bedogna V, Baggio E, Loschiavo C, Mansueto G, Lupo A: Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrol Dial Transplant 2004;19:2325-2333.
25. Ram SJ, Work J, Caldito GC, Eason JM, Pervez A, Paulson WD: A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int 2003;64:272-280.
26. Dember LM, Holmberg EF, Kaufman JS: Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney Int 2004;66:390-398.
27. Shahin H, Reddy G, Sharafuddin M, Katz D, Franzwa BS, Dixon BS: Monthly access flow monitoring with increased prophylactic angioplasty did not improve fistula patency. Kidney Int 2005;68:2352-2361.
28. Krivitski NM: Theory and validation of access flow measurement by dilution technique during hemodialysis. Kidney Int 1995;48:244-250.
29. Besarab A, Sullivan KL, Ross RP, Moritz MJ: Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int 1995;47:1364-1373.
30. Spergel LM, Holland JE, Fadem SZ, McAllister CJ, Peacock EJ: Static intra-access pressure ratio does not correlate with access blood flow. Kidney Int 2004;66:1512-1516.
31. Astor BC, Eustace JA, Klag MJ, Powe NR, Longenecker JC, Fink NE, Marcovina SM, Coresh J: Race-specific association of lipoprotein (a) with vascular access interventions in hemodialysis patients: the CHOICE Study. Kidney Int 2002;61:1115-1123.